James Huang Alaunos Therapeutics, Inc. (TCRT) insider trading activity

TCRT Quotes by TradingView

James Huang is Director of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 188,333 shares of TCRT, which is worth approximately $391,732. The most recent transaction as insider was on Jun 22, 2022, when has been sold 80,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 188K
0% 3M change
0% 12M change
Total Value Held $391,732

James Huang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2022
BUY
Grant, award, or other acquisition
-
80,000 Added 29.81%
188,333 Common Stock
Jun 22 2022
BUY
Grant, award, or other acquisition
-
80,000 Added 29.81%
188,333 Common Stock
Sep 01 2021
BUY
Open market or private purchase
$171,000 $1.71 p/Share
100,000 Added 48.0%
108,333 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
8,333 Added 50.0%
8,333 Common Stock

Also insider at

WINT
WINDTREE THERAPEUTICS INC Healthcare
Director
CASI
CASI Pharmaceuticals, Inc. Healthcare
Director
JH

James Huang

Director
Rockville, MD

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRT